Dose-dependent differential mRNA target selection and regulation by let-7a-7f and miR-17-92 cluster microRNAs

RNA Biology

Volumn 9, Issue 10, 2012, Pages 1275-1287

  Shu, Jingmin ^a   Xia, Zhilian ^a   Li, Lihua ^a   Liang, Ellen T ^a   Slipek, Nicholas ^a   Shen, Dawen ^a   Foo, Jasmine ^b   Subramanian, Subbaya ^a   Steer, Clifford J ^a,b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Dose dependent; Let 7a 7f; MicroRNAs; MiR 17 92; MiRNA target selection; Oncogene; Tumor suppressor gene

Indexed keywords

EID: 84868219536     PISSN: 15476286     EISSN: 15558584     Source Type: Journal    
DOI: 10.4161/rna.21998     Document Type: Article

References (35)

1. Cai X, Hagedorn CH, Cullen BR. Human microR-NAs are processed from capped, polyadenylated transcripts that can also function as mRNAs. RNA 2004; 10:1957-66; PMID:15525708; http://dx.doi.org/10.1261/rna.7135204.
2. Denli AM, Tops BB, Plasterk RH, Ketting R F, Hannon GJ. Processing of primary microRNAs by the Microprocessor complex. Nature 2004; 432:231-5; PMID:15531879; http://dx.doi.org/10.1038/nature03049.
3. Landthaler M, Yalcin A, Tuschl T. The human DiGeorge syndrome critical region gene 8 and Its D. melanogaster homolog are required for miRNA biogenesis. Curr Biol 2004; 14:2162-7; PMID:15589161; http://dx.doi.org/10.1016/j.cub.2004. 11.001.
4. Gregory RI, Yan K P, Amuthan G, Chendrimada T, Doratotaj B, Cooch N, et al. The Microprocessor complex mediates the genesis of microRNAs. Nature 2004; 432:235-40; PMID:15531877; http://dx.doi.org/10.1038/nature03120.
5. Saito K, Ishizuka A, Siomi H, Siomi MC. Processing of pre-microRNAs by the Dicer-1-Loquacious complex in Drosophila cells. PLoS Biol 2005; 3:e235; PMID:15918769; http://dx.doi.org/10.1371/journal. pbio.0030235.
6. Chendrimada T P, Gregory RI, Kumaraswamy E, Norman J, Cooch N, Nishikura K, et al. TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing. Nature 2005; 436:740-4; PMID:15973356; http://dx.doi.org/10. 1038/nature03868.
7. Yeom KH, Lee Y, Han J, Suh MR, Kim VN. Characterization of DGCR8/Pasha, the essential cofac-tor for Drosha in primary miRNA processing. Nucleic Acids Res 2006; 34:4622-9; PMID:16963499; http://dx.doi.org/10.1093/nar/gkl458.
8. Kanellopoulou C, Muljo SA, Kung AL, Ganesan S, Drapkin R, Jenuwein T, et al. Dicer-deficient mouse embryonic stem cells are defective in differentiation and centromeric silencing. Genes Dev 2005; 19:489-501; PMID:15713842; http://dx.doi.org/10.1101/gad.1248505.
9. Murchison E P, Partridge J F, Tam OH, Cheloufi S, Hannon GJ. Characterization of Dicer-deficient murine embryonic stem cells. Proc Natl Acad Sci USA 2005; 102:12135-40; PMID:16099834; http://dx.doi.org/10.1073/pnas. 0505479102.
10. Sood P, Krek A, Zavolan M, Macino G, Rajewsky N. Cell-type-specific signatures of microRNAs on target mRNA expression. Proc Natl Acad Sci USA 2006; 103:2746-51; PMID:16477010; http://dx.doi.org/10.1073/pnas.0511045103.
11. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, et al. MicroRNA expression profiles classify human cancers. Nature 2005; 435:834-8; PMID:15944708; http://dx.doi.org/10.1038/nature03702.
12. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 2006; 103:2257-61; PMID:16461460; http://dx.doi.org/10. 1073/pnas.0510565103.
13. Lewis B P, Burge CB, Bartel D P. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005; 120:15-20; PMID:15652477; http://dx.doi.org/10.1016/j.cell.2004.12.035.
14. Friedman RC, Farh KK, Burge CB, Bartel D P. Most mammalian mRNAs are conserved targets of microR-NAs. Genome Res 2009; 19:92-105; PMID:18955434; http://dx.doi.org/10.1101/gr.082701.108.
15. Betel D, Wilson M, Gabow A, Marks DS, Sander C. The microRNA.org resource: targets and expression. Nucleic Acids Res 2008; 36(Database issue):D149-53; PMID:18158296; http://dx.doi.org/10.1093/nar/gkm995.
16. Griffiths-Jones S, Saini HK, van Dongen S, Enright AJ. miRBase: tools for microRNA genomics. Nucleic Acids Res 2008; 36(Database issue):D154-8; PMID:17991681; http://dx.doi.org/10.1093/nar/gkm952.
17. Lall S, Grün D, Krek A, Chen K, Wang YL, Dewey CN, et al. A genome-wide map of conserved microR-NA targets in C. elegans. Curr Biol 2006; 16:460-71; PMID:16458514; http://dx.doi.org/10.1016/j. cub.2006.01.050.
18. Bartel D P. MicroRNAs: target recognition and regulatory functions. Cell 2009; 136:215-33; PMID:19167326; http://dx.doi.org/10.1016/j.cell.2009.01.002.
19. Shu J, Kren BT, Xia Z, Wong PY, Li L, Hanse EA, et al. Genomewide microRNA down-regulation as a negative feedback mechanism in the early phases of liver regeneration. Hepatology 2011; 54:609-19; PMID:21574170; http://dx.doi.org/10.1002/hep.24421.
20. Zhao Y, Deng C, Wang J, Xiao J, Gatalica Z, Recker RR, et al. Let-7 family miRNAs regulate estrogen receptor alpha signaling in estrogen receptor positive breast cancer. Breast Cancer Res Treat 2011; 127:69-80; PMID:20535543; http://dx.doi.org/10.1007/s10549-010-0972-2.
21. Sampson VB, Rong NH, Han J, Yang Q, Aris V, Soteropoulos P, et al. MicroRNA let-7a down-regulates MYC and reverts MYC-induced growth in Burkitt lymphoma cells. Cancer Res 2007; 67:9762-70; PMID:17942906; http://dx.doi.org/ 10.1158/0008-5472.CAN-07-2462.
22. Thomson DW, Bracken C P, Goodall GJ. Experimental strategies for microRNA target identification. Nucleic Acids Res 2011; 39:6845-53; PMID:21652644; http://dx.doi.org/10.1093/nar/gkr330.
23. Mukherji S, Ebert MS, Zheng GX, Tsang JS, Sharp PA, van Oudenaarden A. MicroRNAs can generate thresholds in target gene expression. Nat Genet 2011; 43:854-9; PMID:21857679; http://dx.doi.org/10.1038/ng.905.
24. He L, Thomson JM, Hemann MT, Hernando-Monge E, Mu D, Goodson S, et al. A microRNA polycistron as a potential human oncogene. Nature 2005; 435:828-33; PMID:15944707; http://dx.doi.org/10.1038/nature03552.
25. Hossain A, Kuo MT, Saunders G F. Mir-17-5p regulates breast cancer cell proliferation by inhibiting translation of AIB1 mRNA. Mol Cell Biol 2006; 26:8191-201; PMID:16940181; http://dx.doi.org/10.1128/MCB.00242-06.
26. Pekarsky Y, Croce CM. Is miR-29 an oncogene or tumor suppressor in CLL? Oncotarget 2010; 1:224-7; PMID:20936047.
27. Salmena L, Poliseno L, Ta y Y, Kats L, Pandolfi P P. A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language? Cell 2011; 146:353-8; PMID:21802130; http://dx.doi.org/10.1016/j.cell.2011.07.014.
28. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 2008; 105:10513-8; PMID:18663219; http://dx.doi.org/10.1073/pnas.0804549105.
29. Bohanes P, Courvoisier DS, Perneger TV, Morel P, Huber O, Roth AD. Survival predictors for second-line chemotherapy in Caucasian patients with metastatic gastric cancer. Swiss Med Wkly 2011; 141:w13249; PMID:21870299.
30. Hu Z, Chen X, Zhao Y, Tian T, Jin G, Shu Y, et al. Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer. J Clin Oncol 2010; 28:1721-6; PMID:20194856; http://dx.doi.org/10.1200/JCO.2009.24.9342.
31. Liu C, Tang DG. MicroRNA regulation of cancer stem cells. Cancer Res 2011; 71:5950-4; PMID:21917736; http://dx.doi.org/10.1158/0008-5472.CAN-11-1035.
32. Cortez MA, Bueso-Ramos C, Ferdin J, Lopez-Berestein G, Sood AK, Calin GA. MicroRNAs in body fluids-the mix of hormones and biomarkers. Nat Rev Clin Oncol 2011; 8:467-77; PMID:21647195; http://dx.doi.org/10.1038/nrclinonc.2011.76.
33. Yoo BJ, Selby MJ, Choe J, Suh BS, Choi SH, Joh JS, et al. Transfection of a differentiated human hepatoma cell line (Huh7) with in vitro-transcribed hepatitis C virus (HCV) RNA and establishment of a long-term culture persistently infected with HCV. J Virol 1995; 69:32-8; PMID:7983724.
34. Takebayashi Y, Goldwasser F, Urasaki Y, Kohlhagen G, Pommier Y. Ecteinascidin 743 induces protein-linked DNA breaks in human colon carcinoma HCT116 cells and is cytotoxic independently of topoisomer-ase I expression. Clin Cancer Res 2001; 7:185-91; PMID:11205907.
35. Li L, Sarver AL, Alamgir S, Subramanian S. Downregulation of microRNAs miR-1, -206 and-29 stabilizes PAX3 and CCND2 expression in rhabdomyosarcoma. Lab Invest 2012; 92:571-83; PMID:22330340; http://dx.doi.org/10.1038/labin-vest. 2012.10.